Malfunctioning immune cell behaviour could be drug target in Long Covid Posted: Thursday, March 16, 2023 Greater Manchester researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of Long COVID. Continue reading full article: Malfunctioning immune cell behaviour could be drug target in Long Covid
Manchester BRC researcher receives prestigious international early career research honour Posted: Monday, October 3, 2022 A researcher at Manchester BRC has won a celebrated international prize, in recognition for his work in respiratory (breathing) research. Continue reading full article: Manchester BRC researcher receives prestigious international early career research honour
‘World-first’ graphene-based test could rapidly detect patients’ need for antibiotic treatment Posted: Wednesday, July 20, 2022 Research into a new generation of a graphene-based diagnostic test – which could identify patients who need antibiotics in minutes, instead of hours – will be delivered in Manchester. Continue reading full article: ‘World-first’ graphene-based test could rapidly detect patients’ need for antibiotic treatment
Manchester BRC researchers receive prestigious national appointments Posted: Monday, March 14, 2022 Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR). Continue reading full article: Manchester BRC researchers receive prestigious national appointments
Global trials show drug eases symptoms of chronic cough Posted: Friday, March 11, 2022 The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects. Continue reading full article: Global trials show drug eases symptoms of chronic cough
COVID-19 study finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised patients Posted: Thursday, February 3, 2022 Professor Paul Dark, Non-fungal Infections Programme Lead, is one of the authors of the paper “Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19,” recently published in JAMA. Continue reading full article: COVID-19 study finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised patients
Indonesian Study reveals missed diagnosis of fungal infections in treated TB patients, with global implications Posted: Tuesday, December 7, 2021 A study of tuberculosis (TB) patients in six Jakarta hospitals has revealed up to 13 per cent of them had fungal lung infection – or aspergillosis – at the end of their treatment. Continue reading full article: Indonesian Study reveals missed diagnosis of fungal infections in treated TB patients, with global implications
Revolutionising the evaluation of COPD flare-ups research outcomes to help COPD patients breathe Posted: Wednesday, November 17, 2021 Dr Alexander Mathioudakis, Respiratory Theme Researcher, and John Linnell, patient participant, discuss an international study that will revolutionise the way COPD exacerbation research outcomes are evaluated and how this could benefit COPD patients in the future. Continue reading full article: Revolutionising the evaluation of COPD flare-ups research outcomes to help COPD patients breathe